Identifying novel therapeutic targets for non-alcoholic fatty liver disease using bioinformatics approaches: from drug repositioning to traditional Chinese medicine
Cyclosporine and TCM compounds are promising candidates for NAFLD treatment, warranting further experimental validation to confirm their therapeutic potential.
Authors
- Tianwei Meng (ORCID: https://orcid.org/0000-0001-8311-6903)
- Xinghua Li (ORCID: https://orcid.org/0000-0002-2971-159X)
- Juan Xu (ORCID: https://orcid.org/0000-0002-3709-4165)
- Jingmin Zhang (ORCID: https://orcid.org/0000-0002-2765-6574)
- Weiqi Gao (ORCID: https://orcid.org/0000-0003-0154-9524)
Institutions
- Changzhi University (CN)
- Shanxi Medical University (CN)
- Heilongjiang University of Chinese Medicine (CN)
- Changzhi Medical College (CN)
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- Frontiers in Bioinformatics
- Published
- 2025-08-26
- DOI
- https://doi.org/10.3389/fbinf.2025.1613985
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00